David Pernock

2017 - Eagle Pharmaceuticals

In 2017, David Pernock earned a total compensation of $3.8M as President and Chief Commercial Officer at Eagle Pharmaceuticals.

Compensation breakdown

Bonus$216,000
Option Awards$3,020,682
Salary$515,000
Other$13,143
Total$3,764,825

Pernock received $3M in option awards, accounting for 80% of the total pay in 2017.

Pernock also received $216K in bonus, $515K in salary and $13.1K in other compensation.

Rankings

In 2017, David Pernock's compensation ranked 2,762nd out of 14,666 executives tracked by ExecPay. In other words, Pernock earned more than 81.2% of executives.

ClassificationRankingPercentile
All
2,762
out of 14,666
81st
Division
Manufacturing
956
out of 5,772
83rd
Major group
Chemicals And Allied Products
255
out of 2,075
88th
Industry group
Drugs
194
out of 1,731
89th
Industry
Pharmaceutical Preparations
154
out of 1,333
88th
Source: SEC filing on April 30, 2018.

Pernock's colleagues

We found five more compensation records of executives who worked with David Pernock at Eagle Pharmaceuticals in 2017.

2017

Scott Tarriff

Eagle Pharmaceuticals

Chief Executive Officer

2017

Adrian Hepner

Eagle Pharmaceuticals

Chief Medical Officer

2017

Steven Krill

Eagle Pharmaceuticals

Chief Scientific Officer

2017

Pete Meyers

Eagle Pharmaceuticals

Chief Financial Officer

2017

David Riggs

Eagle Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like